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Abstract
Background: Kaposiform Hemangioendothelioma (KHE) is a rare vascular tumor of intermediate malignant potential
which shows locally aggressive growth but only rarely metastasizes. It is mostly considered to be a tumor of pediatric
population but its occurrence in the adults is not uncommon as once considered. Histologically, KHE can mimic other
soft tissue neoplasms of different behaviors (e.g. Kaposi Sarcoma, hemangioma) and establishing the correct diagnosis
is important for appropriate treatment. Herein, we describe the clinicopathological features of 8 cases of KHE which will
be helpful in making their diagnosis.
Methods: We reviewed pathology reports, microscopy glass slides and obtained follow up information about 8 cases
of KHE which were diagnosed at our institution from January 2008 till June 2020. Immunohistochemical stain for HHV8
was also performed.
Results: Age ranged from 7 months to 25 years. Seven patients were less than 20 years of age and one patient was 25
years old. Equal gender distribution was observed. Extremities were the most common sites of involvement, followed
by head and neck, pancreas and ischiorectal region. 2 cases were resection specimen and all others were incisional
biopsies. The largest tumor size was 5.5 cm in one of the resections. The incisional/fragmented tissues were all less
than 5 cm in aggregate. Most cases showed predominance of nodular growth and a minor component of spindle cell
population along with lymphangiomatosis like vascular channels, with evidence of microthrombi in 2 cases. Few
multinucleated giant cells were observed in 2 cases. None of the cases exhibited significant nuclear atypia or mitotic
activity. One of the cases arising in dermis showed underlying bone involvement. HHV8 was negative in 7/7 cases.
Conclusions: KHE can also involve adult population and it should always be considered in the differential diagnoses of
a vascular lesion. Presence of multinucleated giant cells is a rare finding. Knowledge about histological features and
potential mimics is helpful in avoiding misdiagnosis.
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Introduction
According to the recent World Health Organization
(WHO) classification of soft tissue tumors, vascular tu-
mors are categorized as benign, intermediate malignant
potential and outright malignant based on risk of metas-
tasis and local recurrence. The intermediate malignant
potential category is further categorized into tumors
which are locally aggressive with a high rate of local re-
currence and those which rarely metastasize to distant
organs. Kaposiform Hemangioendothelioma (KHE) be-
longs to the former subcategory of vascular tumors with
intermediate malignant potential. KHE shows histo-
logical features overlapping with benign hemangioma
and Kaposi Sarcoma (KS) [1]. It is traditionally consid-
ered to be a tumor of infants and children, but many
adult cases have also been reported in the literature [2].
Distal extremities are the classic sites but many unusual
sites including head and neck region and viscera have
also been reported [3]. Once considered to be rare, the
literature search does yield some large series, the largest
reporting 100 cases from a single institution [4]. Micro-
scopically, it shows combination of nodular and spindle
cell growth patterns in varying proportions, which may
be surrounded by ectatic lymphatic channels resembling
lymphangiomatosis in some examples [2]. The nodules
are glomeruloid aggregates of vascular channels, with
variable slit-like lumina and surrounding pericytic layer.
The neoplastic cells have pale eosinophilic cytoplasm
and uniform appearing nuclei with folded contours and
none to minimal atypia [1]. Based on glomeruloid struc-
tures, KHE needs to be differentiated from infantile
hemangioma and tufted angioma, both of which are be-
nign tumors of pediatric population. The spindle cell
component resembles and needs to be differentiated
from KS which is a malignant tumor. Human Herpes
Virus-8 (HHV-8) immunohistochemical (IHC) stain
helps in distinguishing KS from KHE as it is positive in
KS while negative in KHE [5].
In this study, we have described the clinical and histo-
pathological characteristics of 8 cases of KHE which
would be helpful in making their correct diagnosis. We
also attempted to obtain follow up information in order
to understand the behavior and prognosis of this tumor.
Materials and Methods
We searched the surgical pathology database of our in-
stitution through Integrated Laboratory Management
System (ILMS) software for cases diagnosed as “KHE”
from January 2008 till June 2020. Approval by the Insti-
tutional Ethical Review Committee (ERC # 2020-5031-
13950) was sought.
Patient demographics including age, gender, tumor site
and clinical presentation were recorded from surgical
pathology reports. Hematoxylin & eosin stained (H&E)
and IHC stained slides of these cases were retrieved
from the archives and reviewed by 2 pathologists to ob-
serve histological features including the respective per-
centages of nodular and spindle components, nuclear
atypia, presence of multinucleated giant cells, extent of
tumor invasion, mitotic activity, presence of lymphatic
channels, margin status and other unusual morpho-
logical features. Formalin fixed paraffin embedded tissue
blocks were stained with HHV-8 antibody (Clone 13B10
by Cell Marque) according to the manufacturer’s proto-
col by DAKO envision system. All cases were also
stained with CD31, CD34, ASMA and ERG antibodies.
At least 5 % of the tumor cells showing intermediate to
strong nuclear positivity was taken as the cutoff for
HHV-8 positivity [6].
Information regarding subsequent treatment and fol-
low up was obtained from patients via telephonic
conversation.
Results
Clinical features: A total of 8 cases were diagnosed dur-
ing the study period. Table 1 summarizes the features
and follow up information of these 8 cases. 7 of the 8
patients were younger than 20 years of age and only a
single was an adult female. Male to female ratio was 1:1.
Five cases involved distal extremities. One of these cases
(case 2) was limited to the dermis while the rest involved
deeper soft tissue. Another case (case 6) showed infiltra-
tion into underlying bone.
Out of the remaining 3 cases, one arose in the head of
pancreas of an 18-year-old male with classic clinical
signs and symptoms of common bile duct obstruction
i.e. pruritus, jaundice and weight loss. Computed Tom-
ography (CT) scan showed intra and extra-hepatic bil-
iary dilatation along with moderate dilatation of the
pancreatic duct. There was a focus of ill-defined en-
hancement in the peri-ampullary region which indented
the common bile and pancreatic ducts resulting in their
dilatation. Patient underwent Whipple’s procedure for
tumor excision. Second case involved the nose of a 10-
year-old female and third case involved the ischiorectal
region of the only adult patient of our cohort.
2 cases were resection specimen and all others were
incisional biopsies. The largest tumor size was 5.5 cm in
one of the resections. The incisional/fragmented tissues
were all less than 5 cm in aggregate (Table 2). Tumor
was not associated with Kassabech-Meritt Syndrome/
Phenomenon (KMP) in any of the cases. Data regarding
KMP was obtained from the laboratory reports such as
complete blood count, prothrombin time and inter-
national normalized ratio (INR), available on ILMS soft-
ware. Patients were also inquired through telephonic
conversation about their presenting complaints or bleed-
ing crisis.
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Pathological features
In all cases, tumors were predominantly composed of
vascular nodules along with minor component of spindle
cell areas and lymphatic vessels as described in Table 2.
These vascular nodules comprised of endothelial cells
with variable slit-like lumina and cytoplasmic vacuoles
(Fig. 1 a-c). Mitotic figures ranged from 2 to 7 per 10
high power fields (HPFs). The nuclei appeared to be uni-
form with folded contours, fine chromatin and occa-
sional small nucleoli. Perineurial invasion was seen in 2
cases (Fig. 1d). Tumors involving extremities showed in-
filtrating nodules of tumor into dermis and subcutane-
ous fat (Fig. 2 a) along with adnexal involvement
(Fig. 2b). Significant nuclear atypia and necrosis were
not seen in any of the cases. One of the cases showed
prominent lymphatic vessels surrounding the vascular
nodules (Fig. 2 c). Few intratumoral multinucleated giant
cells were seen in 2 of our cases (Fig. 2d). This finding
has not been described previously with KHE. Micro-
thrombi were seen in 2 of our cases (Fig. 2d inset). The
histological features of individual cases are summarized
in Table 2.
CD34, CD31 and ERG showed staining in endothelial
cells (Fig. 3 a-c) and ASMA which showed staining in
pericytic cells surrounding the vascular lumina. HHV-8
was negative in 7 cases in which it was performed
(Fig. 3d). Immunohistochemical markers for lymphatic
channels, like D2-40, LYVE-1 and VEGFR3 were not
performed, as none of these markers are available in our
laboratory.
Follow‐up
7 out of 8 patients in our series were alive and disease
free at the time of obtaining last follow up. None of
them developed recurrence or metastasis. One of the pa-
tients was lost to follow up after 40 months (Table 1).
Discussion
KHE was first described by Zukerberg et al. in 1993 as a
rare vascular tumor of infancy and childhood, arising
most commonly in deep soft tissue of extremities [2].
They delineated the clinical and pathological features of
this distinctive tumor entity in a series of 9 cases [2]. Be-
fore that study was published, KHE was reported as indi-
vidual case reports with vague names like “Kaposi-like
Infantile Hemangioendothelioma” and “Epithelioid and
spindle cell Hemangioendothelioma” [7, 8]. In the series
reported by Zukerberg et al., 7 out of 9 patients were
less than 10 years of age and none was older than 20
years [2]. Subsequent series and case reports described
wide age range starting from antenatal period up to 46
years [9]. In our series, majority of the patients were
children and the age ranged from 7 months to 25 years
(Table 1).
Upper and lower extremities are the most common
sites [2, 4]. This has been followed by mediastinum, ret-
roperitoneum and head and neck region [4, 10–12]. In
2009 Fernandez Y et al. published a review of 165 KHE
cases reported since the first series published in 1993
[3]. Patients ranged from newborns to 64 years of age,
the majority of which were children under 12 years old,
concordant with the earlier descriptions by Zuckerberg
et al. [2]. Around 60 cases reported in that series in-
volved extremities, the rest involved a multitude of sites
[3]. Several studies have described KHE at varied sites
or origin with unusual clinical presentations. Pancreas is
one of the rare sites for KHE and so far, it has only been
reported in 4 cases, all of these patients being less than
2 years of age [13–16]. One of the cases in our series
also involved pancreas. The patient was 18-year-old
male who presented with pruritus, jaundice and weigh
loss. On CT scan, tumor appeared as an ill-defined en-
hancement in the peri-ampullary area which was caus-
ing dilatation of intra and extra-hepatic biliary ducts
and pancreatic ducts. He underwent Whipple’s proced-
ure and was alive and tumor free after 24 months follow
up duration. Other rare tumor sites with unusual clin-
ical presentation have also been described in individual
case reports such as a tumor arising in antecubital fossa
at the site of previous trauma and a fatal tumor inside
the cranial cavity centered on the tentorium cerebelli
[17, 18].
Table 1 Summary of clinical features and follow up information of KH patients (n = 8)
Case # Patient’s age Gender Tumor Site Presenting feature Follow up duration Follow-up status
1 7 months Male Calf Not mentioned 144 months Alive and disease free
2 6 years Female Skin over shin Ulcer 120 months Alive and disease free
3 10 years Female Nose Not mentioned 120 months Alive and disease free
4 2 years Female Metacarpals Not mentioned 96 months Alive and disease free
5 8 months Male Synovium knee Not mentioned 84 months Alive and disease free
6 4 years Male Thigh Not mentioned 40 months Lost to follow up
7 18 years Male Pancreas Common bile duct obstruction 24 months Alive and disease free
8 25 years Female Ischiorectal area Indurated skin 12 months Alive and disease free
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In the dermal and/or subcutaneous locations, KHE
clinically appears as a reddish to violet plaque or nodule,
that can grow deep down into the soft tissue or even
bone, as seen in one of our cases which showed bone in-
filtration (case 6). In deeper locations, the clinical
symptoms depend on the site of tumor involvement. If
tumor involves deep fascial planes, it infiltrates as nod-
ules with surrounding desmoplastic response and it may
present with mass effect. If the tumor involves retroperi-
toneum or visceral organs, the presentation may be with
Fig. 1 Pancreatic KHE. a H&E stained sections of tumor showing predominantly glomeruloid arrangement in this field. These glomeruloid nodules are
composed of closely packed vascular channels lines by single layer of bland endothelial cells. b This area shows predominantly spindle cell growth,
infiltrating into the pancreatic acini. These areas resemble KS. c Other areas of spindle cell growth surrounding lining of a pancreatic duct, where the
spindled endothelial cells grow in sheets with slit like lumina containing variable number of erythrocytes. d Focus of perineurial invasion
Fig. 2 a H&E stained sections of cutaneous KHE, showing glomeruloid nodules of tumor infiltrating into subcutaneous adipose tissue. b In the
dermis, the tumor nodules infiltrate through adnexal structures with entrapment of residual bi-layered eccrine glandular acini. c Tumor nodules
with surrounding lymphangioma-like vascular spaces. d Tumor nodules showing few scattered multinucleated giant cells, which is a rare finding
in KHE. D Inset) Microthrombi seen within capillary lumen
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thrombocytopenic coagulopathy or KMP, which is com-
monly associated with this tumor. In the latter scenario,
the tumor may come to attention after workup of coagu-
lopathy [13].
For our patients, data regarding associated KMP was
collected over telephonic conversation by asking leading
questions like if there was any history of bleeding or
anti-coagulant therapy before or during hospital stay.
The information obtained thus concluded that none of
the cases in our cohort had associated KMP.
Histologically, KHE predominantly comprises of glo-
meruloid proliferation of vascular channels lined by
endothelial cells which are positive for vascular markers
such as CD31 and CD34 [1]. These structures are the
site of sequestration and destruction of red blood cells
and platelets [5]. Smooth muscle actin positive pericytic
cells can also be focally seen surrounding these endothe-
lial cells. Adjacent to these areas, there are ill-defined
zones of lymphatic channels which are found to be posi-
tive for markers of lymphatic differentiation such as D2-
40, LYVE-1 and VEGFR3. These foci may also exhibit
spindle cell proliferation which can mimic KS with for-
mation of slit-like spaces. Distinction from KS is done
by the presence of glomeruloid proliferations and ab-
sence of HHV-8 by either IHC or molecular methods to
detect DNA of the Human Herpes virus 8 [5]. Intracyto-
plasmic vacuoles may be seen in the neoplastic cells,
which is a common finding in vascular neoplasms [19].
We observed intratumoral multinucleated giant cells
in 2 of our cases. To the best of our knowledge, this
finding has not so far been reported in the literature
within KHE. Though studies have described presence of
multinucleated giant cells within other vascular neo-
plasms [20]. Studies conducted on cases of vasculitis
have demonstrated the multinucleated giant cells and
other CD68 positive macrophages as sources of vascular
endothelial growth factor (VEGF) and interferon gamma,
both of which are mediators of angiogenesis [21]. The
presence of these cells thus theoretically may be one of
the underlying mechanisms of vascular proliferation and
tumorigenesis in vascular neoplasms.
Juvenile Hemangioma (JH) can show similar presenta-
tion in the pediatric population but it lacks the typical
rounded nodules of KHE, lacks associated red cell se-
questration and KMP. GLUT1 also helps in distinction
as it is usually expressed in JH while it is negative in
KHE. Tufted Angioma (TA) also presents in the same
pediatric population in the skin as erythematous and
violaceous plaques. Histologically, it also shows cannon
ball-like clusters of capillary sized blood vessels growing
within the dermis [22]. Some authors suggest these 2 en-
tities represent two ends of the histological spectrum
where TA is at the benign end while KHE is at the
aggressive end [4]. On this theme, the recent WHO clas-
sification of tumors of the soft tissue, the two entities
have been combined finally after a long debate [1]. We
also evidenced aggressive local growth in the form of
underlying bone infiltration in one of our cases.
Almost all pediatric cases of KHE described in the litera-
ture had been associated with KMP, particularly those in-
volving deeper soft tissues such as retroperitoneum and
mediastinal cavities [11], though KMP is not exclusive to
Fig. 3 a & b CD34 and CD31 highlighting endothelial cells. c Nuclear staining of ERG in endothelial cells d Negative staining of HHV8
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these tumors and can also be seen with some superficial
tumors arising in the dermis and subcutis [4]. KMP is
characterized by thrombocytopenic coagulopathy and was
first described by Kassabach and Merritt in 1940 as pur-
pura developing in patients with capillary hemangioma
[23]. KHE rarely causes death due to mass effect or metas-
tasis; however, the presence of KMP is associated with sig-
nificant mortality in these patients [24]. Interestingly,
symptoms and laboratory findings related to KMP were
not observed in any case of our study and only 2 cases
showed evidence of microthrombi. In 2005, Gruman and
colleagues described 10 cases of KHE who presented with-
out KMP. All presented as a skin covered soft tissue mass
and the tumor size was less than 8 cm. They found micro-
scopic evidence of platelet trapping and hemosiderin de-
position. They postulated that the lack of clinical
appearance of KMP can be related to small tumor size
[25]. Similarly, in another study, Schmidt et al. reviewed
231 cases of KHE and found that the size of KHE cases
without KMP was less than the cases with KMP (12 cm2
versus 49 cm2). They also noticed that the incidence of
KMP was highest in the infants and it decreased with in-
creasing age. The cases with KMP were located in the ret-
roperitoneum and extra-regional sites [26]. Most of our
cases were incisional biopsies and few were sent as mul-
tiple fragments of tumor tissue, the largest tumor size in
our study was 5.5 cm in the greatest dimension, which is
less than 8 cm as described by Gruman et al. [25]. With
regards to patinets’ age at presentation, our cohort com-
prised of 7 of 8 cases being less than 20 years of age. The
oldest was also young (25 years old). This finding though
contrasts with the literature, we are of the opinion that
the lack of KMP in our cases can be related to small
tumor size. Further studies are needed to find an explan-
ation for this unusual phenomenon.
Like other vascular tumors exhibiting intermediate
malignant behavior, KHE shows aggressive local growth
with infiltration into more than one tissue planes and it
may also recur after incomplete excision. Spontaneous
regression is not known to occur. Complete surgical re-
moval with wide margins is the most common treatment
modality. Combination of corticosteroids and vincristine
is administered for unresectable tumors [27]. Some stud-
ies have also reported good response with interferon
alpha and sirolimus while others didn’t experience any
response to the latter drug [15, 28]. Control over conse-
quences of KMP may require administration of blood
products like fresh frozen plasma and platelets [29].
Conclusions
KHE is an extremely rare vascular tumor which shows
aggressive local growth and may be associated with
KMP. Pediatric population is the most commonly af-
fected; however, adults can also be affected. Apart from
classic presentation in an extremity, rare sites can also
be involved. It may not always be associated with KMP,
particularly in older patients and those with smaller tu-
mors. It should always be considered in the differential
diagnoses of vascular neoplasms in all age groups. Thor-
ough knowledge of histological features of KHE and its
mimics is helpful in reaching accurate diagnoses and ad-
ministering appropriate treatment and management.
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